FIELD: medicine; pharmacology.
SUBSTANCE: invention concerns application of perfluoralkyl-containing metal complex characterised by critically concentrated micelle formation less 10-3 moles/l, hydrodynamic micelle diameter (2Rh) more than 1 nm and proton relaxation in plasma (R1) more than 10 l/mmole-sec, as contrast medium applied to visualise intravascular thrombi during magnetic resonance imaging (MRI).
EFFECT: extended range of agents used as contrast medium for magnetic resonance imaging.
50 cl, 7 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AS CONTRASTING SUBSTANCES IN MAGNETIC-RESONANCE TOMOGRAPHY IN VISUALIZATION OF PATCHES, TUMORS AND NECROSIS | 2001 |
|
RU2290206C2 |
| PERFLUOROALKYL-CONTAINING COMPOUNDS, METHOD FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL AGENT CONTAINING INDICATED COMPOUNDS | 1997 |
|
RU2242477C2 |
| METAL CHELATES HAVING PERFLUORINATED PEG RADICAL, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2007 |
|
RU2470014C2 |
| PERFLUOROALKYL-CONTAINING COMPLEXES WITH POLAR RESIDUES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL AGENT | 2001 |
|
RU2289579C2 |
| PERFLUOROALKYL-CONTAINING COMPLEXES WITH SUGAR RESIDUES, METHODS FOR THEIR PREPARING | 2001 |
|
RU2280644C2 |
| COMPOUND AND METHOD OF PREPARATION THEREOF | 2002 |
|
RU2305096C2 |
| CASCADE POLYMERIC COMPLEXES, PARENT COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2166501C2 |
| CASCADE POLYMER COMPLEXES, DIAGNOSTIC CONTRAST SUBSTANCE CONTAINING THEREOF, AND INTERMEDIATES | 1996 |
|
RU2197495C2 |
| ACCELERATOR SOLUTION AND METHOD OF CURING CURABLE RESINS | 2011 |
|
RU2572965C2 |
| CONJUGATED BISPHOSPHONATES FOR DIAGNOSING AND TREATING BONE DISEASES | 2015 |
|
RU2742660C2 |
